Clin2
NCT07132073Possibly a fitEnrolling by invitation

MRI-guided SBRT for high-risk prostate cancer

Prostate Cancer

Part of Cancer, Kidney & urinary clinical trials.

This study tests a precise radiation treatment for prostate cancer that uses MRI images to guide the radiation beams. It may be an option for men with higher-risk prostate cancer who can have an MRI and have not had radiation before.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You have intermediate, high, or very high risk prostate cancer
  • You are able to have an MRI scan
  • You have not had radiation to the prostate area before
  • If you are elderly, frail, have a large prostate, or had recent TURP, you may still be eligible but require special attention
  • You are willing to undergo a special, precise radiation plan guided by MRI

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04896801Recruiting
MRI-guided radiation for certain prostate cancer risks

This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.

Brussels
NCT07132658Not yet recruiting
MRI-guided short course radiation for prostate cancer

This trial tests a precise, short course of radiation therapy guided by MRI for men with low or favorable intermediate-risk prostate cancer. It aims to offer effective treatment with fewer sessions and fewer side effects.

NCT06508567Recruiting
MRI-Guided Internal Radiation for Returning Prostate Cancer

This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.

Toronto, Ontario
NCT07644598Recruiting· Phase 2
Targeted Radiation Therapy for Low to Intermediate Risk Prostate Cancer

This study tests a new radiation treatment approach that uses MRI imaging to target specific tumor areas within the prostate while reducing radiation to healthy tissue. It may help patients with early-stage prostate cancer get effective treatment with fewer side effects.

Washington D.C., District of Columbia
NCT06171269Recruiting
MRI-guided radiation dose reduction for prostate cancer

This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.

Chicago, Illinois
NCT05864196Recruiting· Phase 1
Testing two-shot prostate radiation with MRI-guided planning

This early-phase study tests a prostate radiation approach given in two treatments, planned using MRI. It’s designed for men with lower-to-intermediate risk prostate cancer and aims to see if this method is safe and works well.

Mineola, New York

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.